ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $147,000 | -40.2% | 225,501 | 0.0% | 0.00% | – |
| Q4 2021 | $246,000 | -40.0% | 225,501 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $410,000 | +142.6% | 225,501 | +252.7% | 0.00% | – |
| Q2 2021 | $169,000 | -26.5% | 63,931 | 0.0% | 0.00% | – |
| Q1 2021 | $230,000 | +42.9% | 63,931 | 0.0% | 0.00% | – |
| Q4 2020 | $161,000 | 0.0% | 63,931 | 0.0% | 0.00% | – |
| Q3 2020 | $161,000 | -23.3% | 63,931 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $210,000 | +33.8% | 63,931 | 0.0% | 0.00% | – |
| Q1 2020 | $157,000 | -48.0% | 63,931 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $302,000 | +10.2% | 63,931 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $274,000 | -26.5% | 63,931 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $373,000 | +52.2% | 63,931 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $245,000 | +105.9% | 63,661 | 0.0% | 0.00% | – |
| Q4 2018 | $119,000 | -41.7% | 63,661 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $204,000 | +6.2% | 63,661 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $192,000 | -23.2% | 63,661 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $250,000 | -5.3% | 63,661 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $264,000 | -32.5% | 63,661 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $391,000 | -1.3% | 63,661 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $396,000 | -0.3% | 63,661 | +1.7% | 0.00% | 0.0% |
| Q1 2017 | $397,000 | +18.5% | 62,587 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $335,000 | -4.8% | 62,587 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $352,000 | +2.3% | 62,587 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $344,000 | -25.9% | 62,587 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $464,000 | -10.8% | 62,587 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $520,000 | -7.3% | 62,587 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $561,000 | -22.9% | 62,231 | +2.5% | 0.00% | -33.3% |
| Q2 2015 | $728,000 | +20.7% | 60,692 | +8.5% | 0.00% | +50.0% |
| Q1 2015 | $603,000 | +117.7% | 55,946 | +2.5% | 0.00% | +100.0% |
| Q4 2014 | $277,000 | +92.4% | 54,566 | 0.0% | 0.00% | – |
| Q3 2014 | $144,000 | -34.5% | 54,566 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $220,000 | -12.0% | 54,566 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $250,000 | +5.5% | 54,566 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $237,000 | +9.7% | 54,566 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $216,000 | +87.8% | 54,566 | 0.0% | 0.00% | – |
| Q2 2013 | $115,000 | – | 54,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |